Anavex Life Sciences Corp (AVXL)

[Jonjones325]

After almost 3 years, Missling knows if 2-73 is worth pursuing. He knows exactly how each patient is progressing. Macfarlane probably knows each one of them personally, including their caretakers.

Why continue to pursue? After all this time, you know. Why increase IP protection? Why spend more time, money and resources? It’s not like he doesn’t have a back up in 3-71.

We have seen no movement in 3-71. If there was even a small doubt as to the effectiveness of 2-73, 3-71 would have been moving along. Common sense tells us we have a winner.

Illumina, Ariana, and preclinicals have told him to forge ahead. Everything until this point has told us to keep moving. No warning signs to slow down, that we know of. No warning signs to change course.

We now have better funding, cherry picked patients, 2 trials starting. Sitting here at 3 is FN ridiculous.

Missling said he had a sigh of relief when he saw the Illumina data.
Missling said when you look back and see what we did, you will understand why.
Missling said we tried to fail early and didn’t.
Missling said that the sp would be higher once they saw our data.
Missling said our sample size is more than sufficient.
Missling said etc. etc. etc. I can go on and on.

When we spoke. He was excited. He was confident. And it seemed genuine.

I believe him!! Let’s tear up this conference and shut everybody up!!!